Large-scale testing (Phase 3)Study completedNCT02394795What this trial is testingPanitumumab and RAS, Diagnostically-useful Gene Mutation for mCRCWho this might be right forColorectal Cancer Takeda 823
Early research (Phase 1)Study completedNCT00648102What this trial is testingPhase I Study of CDX-1307, hCG-B Vaccine, for Patients With Incurable, Locally Advanced or Metastatic Breast, Colorectal, Pancreatic, Bladder or Ovarian CancerWho this might be right forBreast CancerColorectal CancerPancreatic Cancer+2 more Celldex Therapeutics 36
Testing effectiveness (Phase 2)Study completedNCT01252628What this trial is testingPhase 1 and 2 Study of PX-866 and CetuximabWho this might be right forIncurable Metastatic Colorectal CarcinomaIncurable Progressive, Recurrent or Metastatic Squamous Cell Carcinoma of the Head and Neck Cascadian Therapeutics Inc. 178
Post-approval studies (Phase 4)WithdrawnNCT00510627What this trial is testingStudy Comparing Radio Frequency Ablation Plus Chemotherapy and Chemotherapy Alone in Patients With Secondary Liver MetastasesWho this might be right forMetastatic Liver CancerSecondary Liver CancerLiver Neoplasm Boston Scientific Corporation
Early research (Phase 1)Study completedNCT01843725What this trial is testingPhase 1 Study Testing the Combination of Aflibercept and Capecitabine in Metastatic Digestive and Breast CancersWho this might be right forMetastatic Colorectal CancersMetastatic Gastric CancersMetastatic Oesophageal Cancers+3 more Jules Bordet Institute 37
Early research (Phase 1)Study completedNCT00709462What this trial is testingCDX-1307, in Patients With Incurable Breast, Colorectal, Pancreatic, Ovarian or Bladder Cancer (CDX 1307-01)Who this might be right forBreast CancerColorectal CancerPancreatic Cancer+2 more Celldex Therapeutics 48
Early research (Phase 1)Study completedNCT00535353What this trial is testingAZD2281 and Irinotecan in Treating Patients With Locally Advanced or Metastatic Colorectal CancerWho this might be right forColorectal Cancer NCIC Clinical Trials Group 26